<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Clinical Trials for Psilocybin Indicate No Adverse Effects
Image Overlay - Clinical Trials for Psilocybin Indicate No Adverse Effects

Clinical Trials for Psilocybin Indicate No Adverse Effects

January 29, 2020

Clinical Trials for Psilocybin Indicate No Adverse Effects

A phase I clinical trial conducted by researchers at King's College London and mental healthcare company Compass Pathways, indicates that the drug psilocybin has no adverse effects. Psilocybin induces hallucinogenic symptoms, which may be advantageous for some suffering from chronic depression. Yourway is able to transport even controlled substances across our global network.

Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Clinical Trial Supply West Coast

September 22-23, 2026
Burlingame, CA

Clinical Trial Supply Forum US

October 6-7, 2026
San Francisco, CA

Media

Articles

The Power of Partnership: Why Great Clinical Trials Are Never Built Alone

Open chat
Come chat with us!
Hello! How can I help you?